Joel A. Saydoff
Neuroscience Research
Wellstat Therapeutics Corporation
930 Clopper Road
Gaithersburg
USA
[email]@wellstattherapeutics.com
Name/email consistency: high
- Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease. Saydoff, J.A., Garcia, R.A., Browne, S.E., Liu, L., Sheng, J., Brenneman, D., Hu, Z., Cardin, S., Gonzalez, A., von Borstel, R.W., Gregorio, J., Burr, H., Beal, M.F. Neurobiol. Dis. (2006)
- Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Saydoff, J.A., Liu, L.S., Garcia, R.A., Hu, Z., Li, D., von Borstel, R.W. Brain Res. (2003)









